Trial · NCT03135548
Adverse events270
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 270
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gastroenteritis | Infections and infestations | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Periodontitis | Infections and infestations | BI 655130 Low Dose | 1 | 19 | |
| other | Periodontitis | Infections and infestations | BI 655130 High Dose | 0 | 19 | |
| other | Periodontitis | Infections and infestations | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Sinusitis | Infections and infestations | BI 655130 Low Dose | 1 | 19 | |
| other | Sinusitis | Infections and infestations | BI 655130 High Dose | 0 | 19 | |
| other | Sinusitis | Infections and infestations | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | BI 655130 Low Dose | 1 | 19 | |
| other | Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | BI 655130 High Dose | 0 | 19 | |
| other | Benign neoplasm of thyroid gland | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | BI 655130 Low Dose | 1 | 19 | |
| other | Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | BI 655130 High Dose | 0 | 19 | |
| other | Skin papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Anaemia | Blood and lymphatic system disorders | BI 655130 Low Dose | 1 | 19 | |
| other | Anaemia | Blood and lymphatic system disorders | BI 655130 High Dose | 0 | 19 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo Matching to BI 655130 | 0 | 21 | |
| other | Leukocytosis | Blood and lymphatic system disorders | BI 655130 Low Dose | 1 | 19 | |
| other | Leukocytosis | Blood and lymphatic system disorders | BI 655130 High Dose | 0 | 19 | |
| other | Leukocytosis | Blood and lymphatic system disorders | Placebo Matching to BI 655130 | 1 | 21 | |
| other | Alcohol intolerance | Metabolism and nutrition disorders | BI 655130 Low Dose | 1 | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03135548/events?page=2